As in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best
chance for durable remission in older patients (≥ 60 years) with acute myeloid leukemia …

Fludarabine with busulfan (FB) or melphalan (FM) are 2 more commonly used reduced-
intensity conditioning (RIC) regimens for allogeneic stem cell transplantation (HCT). We …

The optimal conditioning regimen for older patients with acute myeloid leukemia (AML)
remains unclear. In this study, we compared outcomes of AML patients> 60 years of age …

The aim of this study is to compare clinical outcomes of patients who underwent allogeneic
stem cell transplantation (HCT) for myelofibrosis with reduced intensity conditioning (RIC) …

Background The incidence of secondary malignancies associated with busulfan exposure is
considered low, but has been poorly characterized. Because this alkylating agent is …

The optimal conditioning regimen for elderly patients undergoing allogeneic hematopoietic
stem cell transplantation (allo-HCT) remains unclear. We retrospectively analyzed 1607 …

There is a lack of large comparative study on the outcomes of reduced intensity conditioning
(RIC) in acute myeloid leukemia (AML) transplantation using fludarabine/busulfan (FB) and …

The optimal reduced-intensity conditioning (RIC) for patients with acute lymphoblastic
leukemia (ALL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) …

Therapy-related myelodysplastic syndrome is a long-term complication of cancer treatment
in patients receiving cytotoxic therapy, characterized by high-risk genetics and poor …

Reduced-intensity conditioning (RIC) regimens developed to extend the use of allogeneic
hematopoietic stem cell transplantation (HSCT) to older patients have resulted in …